Brief: Lexicon Pharmaceuticals Regains Compliance With Nasdaq Minimum Bid Price Requirement
31/07/2025 14:04
July 31 (Reuters) - Lexicon Pharmaceuticals Inc LXRX.O: LEXICON PHARMACEUTICALS REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE REQUIREMENT Source text: ID:nGNXtgFfM Further company coverage: LXRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lexicon Pharmaceuticals
See all newsLexicon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Lexicon Pharmaceuticals posts Q2 net loss
Brief: Lexicon Pharmaceuticals Q2 EPS USD -0.07
Lexicon Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview
Lexicon Pharmaceuticals Inc expected to post a loss of 5 cents a share - Earnings Preview